Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
MEBO Wound Dressing is a topical medical device developed by Shantou MEBO, specifically designed for the management of chronic and acute wounds, including diabetic ulcers, bedsores (pressure ulcers), skin soft tissue ulcers, and donor site wounds. The product is based on the principles of Moist Exposed Burn Therapy (MEBT) and Moist Wound Healing Therapy (MWHT). It functions by creating and maintaining a physiological moist environment at the wound site, which facilitates the autolytic debridement of necrotic tissue and promotes the natural regeneration of skin cells. The formulation typically consists of a base of sesame oil and beeswax, which provides a protective physical barrier against external contaminants and infection while preventing wound dehydration. It is widely used in regenerative medicine to support the healing of complex skin injuries without the need for traditional skin grafting in some cases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on MEBO Wound Dressing.